Cargando…
Phase 1/2 Study of the Timing and Efficacy of 3 mg Peg-GCSF in Neo/Adjuvant Dose Dense Breast Cancer Treatment Protocols
Background Peg-GCSF has similar efficacy at a dose of 60 µg/kg and 100 µg/kg. The conventional 6 mg SC dose was based on the maximum tolerable dose. In Japan, 3.6 mg dose was approved on the basis of dose finding studies. Peg-GCSF is an integral part of dose-dense chemotherapy protocols. Dose findi...
Autores principales: | Patel, Amol, Pathak, Abhishek, Sarin, Arti, Shelly, Divya, Ranjan, Richa, Singh, Arashdeep, Kala, Tripti, PV, Babitha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691905/ https://www.ncbi.nlm.nih.gov/pubmed/38047054 http://dx.doi.org/10.1055/s-0042-1757599 |
Ejemplares similares
-
Granulocyte colony-stimulating factor (GCSF) fused with Fc Domain produced from E. coli is less effective than Polyethylene Glycol-conjugated GCSF
por: Do, Bich Hang, et al.
Publicado: (2017) -
Expression of granulocyte colony stimulating factor (GCSF) in Hansenula polymorpha
por: Talebkhan, Yeganeh, et al.
Publicado: (2016) -
G-CSF utilization rate and prescribing patterns in United States: associations between physician and patient factors and GCSF use
por: Barnes, Gisoo, et al.
Publicado: (2014) -
Extension of human GCSF serum half-life by the fusion of albumin binding domain
por: Nikravesh, Fatemeh Yadavar, et al.
Publicado: (2022) -
Production of PEGylated GCSF from Non-classical Inclusion Bodies Expressed in Escherichia coli
por: Trinh, Nguyen Thi My, et al.
Publicado: (2021)